ClinicalTrials.Veeva

Menu

Prospective, Randomised Multicenter Study Comparing the Efficacy of Transbronchial Forceps Biopsy With Cryobiopsy to Diagnose Interstitial Lung Disease. (TRABIS)

U

University Hospital Tuebingen

Status

Completed

Conditions

Interstitial Lung Disease

Treatments

Procedure: transbronchial lung biopsy

Study type

Interventional

Funder types

Other

Identifiers

NCT01894113
TBB2010

Details and patient eligibility

About

The use of cryoprobes improves the diagnostic yield in transbronchial biopsies compared to forceps biopsies to diagnose an interstitial lung disease

Full description

Endoscopic biopsy currently plays only a minor role for the diagnosis of interstitial lung disease. However, in some cases obtaining lung tissue is necessary to establish a final diagnosis. The current standard procedure is transbronchial forceps biopsy - if not sufficient: surgical lung biopsy. Transbronchial lung biopsy bears essential limitations however:

  • Small tissue sample
  • Limited evaluability of the material caused by forceps-induced crush artifacts

In cryobiopsy the cryoprobe´s tip is being cooled and thereby cools the surrounding tissue to approximately minus 89 degrees Celsius. Subsequently, the frozen probe is retracted with the frozen tissue being attached onto the frozen probe's tip. When applied in the central airways, cryobiopsy proved to deliver large specimens of good quality, which may exceed forceps biopsies in terms of diagnostic yield. Pilot studies on transbronchial cryobiopsy showed that same advantages as seen in the endobronchial use.

Enrollment

382 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Clinical indications for biopsy of interstitial lung disease
  2. Age over 18 years
  3. Signed consent

Exclusion criteria

  1. Risk of bleeding / ongoing anticoagulation
  2. Oxygen saturation <90% - despite delivery of 2l oxygen / min
  3. Underlying cardiac disease (unstable angina, myocardial infarction during the last month, congestive heart failure)
  4. Pulmonary hypertension, PAP sys> 50mmHg

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

382 participants in 2 patient groups

transbronchial forceps lung biopsy
Active Comparator group
Description:
transbronchial lung biopsy forceps
Treatment:
Procedure: transbronchial lung biopsy
transbronchail cryo lung biopsy
Active Comparator group
Description:
transbronchial lungbiopsy with cryoprobe
Treatment:
Procedure: transbronchial lung biopsy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems